Literature DB >> 23238448

Inflammation in uveal melanoma.

I H G Bronkhorst1, M J Jager.   

Abstract

Leukocytic infiltration is a common feature of human cancers, including those that develop in immunoprivileged sites, such as the eye. The infiltration of myeloid and T cells into tumours is part of the host response against cancer. In uveal melanoma, high densities of immune cells seem to be involved in tumour progression, as they are associated with the loss of one chromosome 3. The nature of this tumour microenvironment might offer therapeutic opportunities.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23238448      PMCID: PMC3574253          DOI: 10.1038/eye.2012.253

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  50 in total

1.  Ipilimumab plus dacarbazine for previously untreated metastatic melanoma.

Authors:  Caroline Robert; Luc Thomas; Igor Bondarenko; Steven O'Day; Jeffrey Weber; Claus Garbe; Celeste Lebbe; Jean-François Baurain; Alessandro Testori; Jean-Jacques Grob; Neville Davidson; Jon Richards; Michele Maio; Axel Hauschild; Wilson H Miller; Pere Gascon; Michal Lotem; Kaan Harmankaya; Ramy Ibrahim; Stephen Francis; Tai-Tsang Chen; Rachel Humphrey; Axel Hoos; Jedd D Wolchok
Journal:  N Engl J Med       Date:  2011-06-05       Impact factor: 91.245

Review 2.  Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm.

Authors:  Subhra K Biswas; Alberto Mantovani
Journal:  Nat Immunol       Date:  2010-09-20       Impact factor: 25.606

3.  Inflammatory cytokines in eyes with uveal melanoma and relation with macrophage infiltration.

Authors:  Long V Ly; Inge H G Bronkhorst; Els van Beelen; Johannes Vrolijk; Andrew W Taylor; Mieke Versluis; Gregorius P M Luyten; Martine J Jager
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06-10       Impact factor: 4.799

Review 4.  Macrophages in uveal melanoma and in experimental ocular tumor models: Friends or foes?

Authors:  Martine J Jager; Long V Ly; Mariam El Filali; Michele C Madigan
Journal:  Prog Retin Eye Res       Date:  2010-12-01       Impact factor: 21.198

5.  Detection of M2-macrophages in uveal melanoma and relation with survival.

Authors:  Inge H G Bronkhorst; Long V Ly; Ekaterina S Jordanova; Johannes Vrolijk; Mieke Versluis; Gregorius P M Luyten; Martine J Jager
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-03       Impact factor: 4.799

Review 6.  Estimating prognosis for survival after treatment of choroidal melanoma.

Authors:  Bertil Damato; Antonio Eleuteri; Azzam F G Taktak; Sarah E Coupland
Journal:  Prog Retin Eye Res       Date:  2011-05-30       Impact factor: 21.198

7.  Tumor cell programmed death ligand 1-mediated T cell suppression is overcome by coexpression of CD80.

Authors:  Samuel T Haile; Jacobus J Bosch; Nnenna I Agu; Annette M Zeender; Preethi Somasundaram; Minu K Srivastava; Sabine Britting; Julie B Wolf; Bruce R Ksander; Suzanne Ostrand-Rosenberg
Journal:  J Immunol       Date:  2011-05-09       Impact factor: 5.422

Review 8.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

Review 9.  Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication.

Authors:  Sergio A Quezada; Karl S Peggs; Tyler R Simpson; James P Allison
Journal:  Immunol Rev       Date:  2011-05       Impact factor: 12.988

Review 10.  Tumor immunosurveillance in human cancers.

Authors:  Bernhard Mlecnik; Gabriela Bindea; Franck Pagès; Jérôme Galon
Journal:  Cancer Metastasis Rev       Date:  2011-03       Impact factor: 9.264

View more
  27 in total

Review 1.  Macrophage physiology in the eye.

Authors:  Holly R Chinnery; Paul G McMenamin; Samantha J Dando
Journal:  Pflugers Arch       Date:  2017-02-23       Impact factor: 3.657

2.  Immune oppression array elucidating immune escape and survival mechanisms in uveal melanoma.

Authors:  Fang Hou; Qi-Ming Huang; Dan-Ning Hu; Jost B Jonas; Wen-Bin Wei
Journal:  Int J Ophthalmol       Date:  2016-12-18       Impact factor: 1.779

3.  Expression of Antimicrobial Peptides by Uveal and Cutaneous Melanoma Cells and Investigation of Their Role in Tumor Cell Migration and Vasculogenic Mimicry.

Authors:  Joseph C Manarang; Deborah C Otteson; Alison M McDermott
Journal:  Curr Eye Res       Date:  2017-09-14       Impact factor: 2.424

4.  Identification of canonical NFκB (C-NFκB) pathway in uveal melanoma and their relation with patient outcome.

Authors:  Mithalesh Kumar Singh; Lata Singh; Neelam Pushker; Neeru Saini; Rachna Meel; Kunzang Chosdol; Sameer Bakhshi; Seema Sen; Pradeep Venkatesh; Bhavna Chawla; Jasbir Kaur; Seema Kashyap
Journal:  Clin Exp Metastasis       Date:  2019-05-08       Impact factor: 5.150

Review 5.  Recent Advances and Challenges in Uveal Melanoma Immunotherapy.

Authors:  Yihang Fu; Wei Xiao; Yuxiang Mao
Journal:  Cancers (Basel)       Date:  2022-06-23       Impact factor: 6.575

6.  Identification of molecular subtyping system and four-gene prognostic signature with immune-related genes for uveal melanoma.

Authors:  Fei Xia; Zhilong Yu; Aijun Deng; Guohong Gao
Journal:  Exp Biol Med (Maywood)       Date:  2021-11-07

7.  Tumour Expression of Histone Deacetylases in Uveal Melanoma.

Authors:  Louis Levinzon; Michele Madigan; Vuong Nguyen; Enisa Hasic; Max Conway; Svetlana Cherepanoff
Journal:  Ocul Oncol Pathol       Date:  2018-09-18

8.  Five Decades of Enucleations for Uveal Melanoma in One Center: More Tumors with High Risk Factors, No Improvement in Survival over Time.

Authors:  Christine D M Roelofsen; Annemijn P A Wierenga; Sjoerd van Duinen; Robert M Verdijk; Jaco Bleeker; Marina Marinkovic; Gregorius P M Luyten; Martine J Jager
Journal:  Ocul Oncol Pathol       Date:  2020-12-15

Review 9.  Upcoming translational challenges for uveal melanoma.

Authors:  Nabil Amirouchene-Angelozzi; Marie Schoumacher; Marc-Henri Stern; Nathalie Cassoux; Laurence Desjardins; Sophie Piperno-Neumann; Olivier Lantz; Sergio Roman-Roman
Journal:  Br J Cancer       Date:  2015-10-27       Impact factor: 7.640

Review 10.  Animal Models of Uveal Melanoma: Methods, Applicability, and Limitations.

Authors:  Marta M Stei; Karin U Loeffler; Frank G Holz; Martina C Herwig
Journal:  Biomed Res Int       Date:  2016-06-06       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.